Command Palette

Search for a command to run...

fredun-pharmaceuticals

1466+2.51%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

Fredun Pharmaceuticals Ltd. lags significantly behind its peers in key financial metrics such as revenue growth, profitability, and efficiency. While it has no debt, its lack of growth and profitability highlights it as a potential underperformer in the sector. In contrast, companies like Mankind Pharma and Dr. Reddy's Laboratories showcase strong growth and profitability, making them sector leaders.

Key Points
  • Fredun Pharmaceuticals has zero revenue growth and profitability metrics (EPS, ROE, etc.).
  • Mankind Pharma leads in revenue growth and profitability metrics, while Sun Pharma has high returns but poor growth.
  • Cipla and Dr. Reddy's show a balanced approach with good growth and profitability, offering strong sector performance.
Top Performers
Mankind Pharma Ltd.

Highest revenue growth (YoY: 18.12%) and strong profitability (ROE: 23.15%)

Dr. Reddy's Laboratories Ltd.

Consistently strong profitability (ROE: 21.76%) and reasonable valuation metrics (PE: 15.50)

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.